Industry News
DLM Invista Closes Contribution to Pharmaceutical Networking Platform
2 September 2013
(Valor) In times of social networks, Interplayers, a company that created a system that connects the various agents of the pharmaceutical chain, received a capital injection from DLM Invista. Leading laboratories in the country, as well as distributors and nearly 50,000 pharmacies are already connected in the platform. The fund will hold a 25% stake in the company. Transaction values were not disclosed. Read more at Valor
You may be interested in...
-
Allianz in LatAm; Across Capital’s ~USD115m Final Close; JICA, DFC, IDB Lab Newest Fund Commitments
-
Nominations Open for LAVCA Deal Awards; BTG Pactual TIG Secures USD500m for Reforestation Strategy
-
Nominations Open for 2025 LAVCA Women Investors in Private Capital; New LAVCA Q3 Industry Data; Vinci Partners Acquires Controlling Stake in Outback’s Brazilian Operations
-
Allianz X Leads USD300m Series E for Argentina’s Ualá
Allianz X led a USD300m Series E for Argentina-based fintech Ualá, with participation...